- Home
- MYNZ vs LCFY Comparison
MYNZ vs LCFY Comparison
Compare MYNZ & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- LCFY
- Stock Information
- Founded
- MYNZ 2021
- LCFY 2009
- Country
- MYNZ Germany
- LCFY Australia
- Employees
- MYNZ N/A
- LCFY N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- LCFY
- Sector
- MYNZ Health Care
- LCFY
- Exchange
- MYNZ Nasdaq
- LCFY Nasdaq
- Market Cap
- MYNZ 7.9M
- LCFY 9.2M
- IPO Year
- MYNZ 2021
- LCFY 2022
- Fundamental
- Price
- MYNZ $1.28
- LCFY $3.97
- Analyst Decision
- MYNZ Buy
- LCFY
- Analyst Count
- MYNZ 2
- LCFY 0
- Target Price
- MYNZ $14.00
- LCFY N/A
- AVG Volume (30 Days)
- MYNZ 133.9K
- LCFY 23.0K
- Earning Date
- MYNZ 12-29-2025
- LCFY 11-10-2025
- Dividend Yield
- MYNZ N/A
- LCFY N/A
- EPS Growth
- MYNZ N/A
- LCFY N/A
- EPS
- MYNZ N/A
- LCFY N/A
- Revenue
- MYNZ $659,935.00
- LCFY $2,231,313.00
- Revenue This Year
- MYNZ N/A
- LCFY N/A
- Revenue Next Year
- MYNZ $5.03
- LCFY N/A
- P/E Ratio
- MYNZ N/A
- LCFY N/A
- Revenue Growth
- MYNZ N/A
- LCFY N/A
- 52 Week Low
- MYNZ $1.21
- LCFY $2.51
- 52 Week High
- MYNZ $14.39
- LCFY $13.98
- Technical
- Relative Strength Index (RSI)
- MYNZ 32.80
- LCFY 26.59
- Support Level
- MYNZ $1.43
- LCFY $3.80
- Resistance Level
- MYNZ $1.47
- LCFY $4.31
- Average True Range (ATR)
- MYNZ 0.10
- LCFY 0.25
- MACD
- MYNZ -0.02
- LCFY -0.05
- Stochastic Oscillator
- MYNZ 12.77
- LCFY 8.80
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.